Marina
Pellon-Consunji

Marina
Pellon-Consunji

Board Member

Marina is a Partner at Ampersand Capital Partners, a healthcare-focused growth equity firm with over $3 billion under management.

Prior to joining Ampersand in 2013, she was an Associate Director in Healthcare Investment Banking at UBS where she worked on a number of leveraged buyouts, mergers and acquisitions, and debt and equity financings for middle-market healthcare companies.

In addition to serving on the Board of VIVEbiotech, Marina’s current and past board seats include GeneWerk, Gyros PTI, Protagene, and Vibalogics.

Marina holds a B.A. with Honors from Wellesley College where she majored in Biological Chemistry and International Relations. After finishing her degree, she worked at biochemistry laboratories at Harvard Medical School.

Marina Pellón Consunji